Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 16 05 2017
accepted: 25 01 2018
pubmed: 3 2 2018
medline: 9 4 2019
entrez: 3 2 2018
Statut: ppublish

Résumé

To assess the type and degree of both red-green and blue-yellow color vision deficiencies of Calabrian males affected by multiple sclerosis. Eighty Calabrian male patients were enrolled (age range 18-70 years; mean age 40.6 ± 12.4 years) showing a disease duration mean of 10.6 ± 8.2 years (range = 0.5-46 years) coming from the Institute of Neurology, Magna Graecia University, Catanzaro. Optic neuritis present in the medical histories of the 21 patients does not influence color vision. Excluding seven colorblind subjects and one affected by a bilateral maculopathy, the analyzed sample group was 72. Seventy controls were matched for age and sex. An ophthalmologist examined all patients and controls in order to rule out diabetic retinopathy, cataracts, senile maculopathy, or ocular fundus' anomalies. The Ishihara test identified the colorblind patients. The City University Test screened for people with abnormal color vision by grading the severity of color vision deficiency. The second part of the City University Test as well as the Farnsworth Test confirmed both the color vision deficiency type and degree. Fifty-one percentage (37/72) of the patients showing a color vision deficiency were subdivided into two subgroups: subgroup one showed red-green deficiency (57%, 21/37); subgroup two showed a coupled red-green and blue-yellow deficiency (43%, 16/37). Furthermore, we found two distinct curves showing a groove within the first 10 years of the disease. Both monocular and binocular analyses allowed us to identify the patients showing the monocular color vision deficiency, but they were well compensated by binocular vision. We think that the majority of the patients with the red-green deficiency will develop the coupled red-green and blue-yellow deficiency in the latter years of multiple sclerosis.

Identifiants

pubmed: 29392642
doi: 10.1007/s10792-018-0838-x
pii: 10.1007/s10792-018-0838-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-676

Références

Am J Hum Biol. 2000 Jan;12(1):17-24
pubmed: 11534000
Am J Optom Arch Am Acad Optom. 1959 Apr;36(4):169-93
pubmed: 13649873
Nature. 1961 Apr 22;190:372-3
pubmed: 13764598
Clin Exp Optom. 2006 Mar;89(2):73-80
pubmed: 16494609
Eur J Neurol. 2006 Jul;13(7):700-22
pubmed: 16834700
J Opt Soc Am. 1945 Dec;35:761-6
pubmed: 21007810
J Parkinsons Dis. 2014;4(3):317-9
pubmed: 24796233
Curr Top Behav Neurosci. 2015;26:29-56
pubmed: 25690593
J Neurol. 2015 Nov;262(11):2491-7
pubmed: 26259563
Neurosci Biobehav Rev. 2016 Aug;67:137-46
pubmed: 26773723
Ophthalmic Physiol Opt. 1985;5(2):185-94
pubmed: 3875069
Acta Ophthalmol (Copenh). 1969;47(3):523-34
pubmed: 5307562
Neurology. 1979 Sep;29(9 Pt 1):1228-35
pubmed: 573402
Br J Physiol Opt. 1966;23(3):186-209
pubmed: 5973345
Ophthalmic Physiol Opt. 1997 May;17(3):248-54
pubmed: 9196667

Auteurs

Anna Piro (A)

National Researches Council, Institute of Molecular Bioimaging and Physiology, Research Section, Viale Europa, 88100, Germaneto (Catanzaro), Italy. anna.piro@cnr.it.

Antonio Tagarelli (A)

National Researches Council, Institute of Molecular Bioimaging and Physiology, Research Section, Viale Europa, 88100, Germaneto (Catanzaro), Italy.

Giuseppe Nicoletti (G)

National Researches Council, Institute of Molecular Bioimaging and Physiology, Research Section, Viale Europa, 88100, Germaneto (Catanzaro), Italy.

Sara Scannapieco (S)

Institute of Neurology, Magna Graecia University, Catanzaro, Italy.

Serena Polidoro (S)

Institute of Neurology, Magna Graecia University, Catanzaro, Italy.

Paola Valentino (P)

Institute of Neurology, Magna Graecia University, Catanzaro, Italy.

Aldo Quattrone (A)

National Researches Council, Institute of Molecular Bioimaging and Physiology, Research Section, Viale Europa, 88100, Germaneto (Catanzaro), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH